Reliefband® Wearable Devices for the Prevention and Treatment of Nausea Symptoms Receive FDA Approval for Expanded Uses

Monday, January 6, 2020 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

FDA Clears Indications for Nausea and Vomiting Related to Physician-Diagnosed Migraines as well as Anxiety and Hangovers

LAS VEGAS, Jan. 6, 2020 /PRNewswire-PRWeb/ -- Reliefband Technologies LLC, an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, announced its Reliefband® family of wearable therapeutic devices have received U.S. Food and Drug Administration (FDA) expanded indication clearance for nausea and vomiting associated with anxiety, hangovers and physician-diagnosed migraines.

The expanded use indications were approved for Reliefband products including the Classic and Premier models, as well as the new Reliefband Travel and Reliefband Sport models unveiled today at CES 2020. The expanded indications join Reliefband's existing FDA-approved indications for symptoms associated with motion sickness, chemotherapy, morning sickness and nausea from postoperative surgery (as an adjunct to antiemetics).

Reliefband is an over-the-counter transdermal neuromodulation device that is applied to the underside of the wrist. Reliefband works by emitting gentle electrical pulses that stimulate the underlying median nerve. The signals generated on the underside of the wrist then flow to the central nervous system where they work, via the vagus nerve, to normalize stomach rhythms that cause nausea and prevent it.

"There are more than 38 million people in the U.S. who suffer migraines and the most common associated symptoms are nausea and vomiting. These newly-cleared indications mark an important step in our mission to mitigate the serious health issues and utter misery associated with nausea," explained Rich Ransom, President and CEO of Reliefband Technologies, LLC. "We will continue to innovate our Reliefband technology, providing relief to those who suffer debilitating symptoms stemming from migraines, hangovers, anxiety and more."

Reliefband will demonstrate the new Travel and Sport wearable devices and its entire family of products at CES 2020 from January 7-10 at the Sands Expo Convention Center, Tech West booth #46052 in the Wearables section and at CES Unveiled at Shorelines Exhibit Hall, Mandalay Bay on Sunday, January 5 from 5:00pm to 8:30pm at table #231.

For more information, please visit http://www.Reliefband.com.

About Reliefband® Technologies, LLC

Reliefband is a world leader in neuromodulation and wearable technology. The company's patented, clinically proven wearable solution prevents and treats nausea and vomiting. Its unique, FDA-cleared neuromodulation technology was originally developed for use in hospitals and alters nerve activity through targeted delivery of gentle pulses to the underside of the wrist to "turn off" feelings of nausea and vomiting. Reliefband is a drug-free alternative that eliminates the discomfort associated with nausea and vomiting. The Reliefband wearable solution has been an industry leader for more than 20 years and is available OTC, at Reliefband.com and Amazon.com. For more information, visit http://www.Reliefband.com.

 

SOURCE Reliefband Technologies



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Diabetes Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store